NEW YORK (GenomeWeb News) – Quest Diagnostics today reported a 4 percent drop year over year in fourth-quarter sales as Hurricane Sandy shrank revenues by $21 million.

For the three months ended Dec. 31, 2012, revenues totaled $1.77 billion, down from $1.85 billion a year ago and short of the consensus Wall Street estimate of $1.80 billion.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.